Core Scientific, Inc. Common Stock (CORZ)
Official siteTECHNOLOGY • SOFTWARE - INFRASTRUCTURE • NASDAQ
Market Cap: $4.38B
Last updated: Nov 17, 2026 at 4:40 PM ET
Core Scientific, Inc. Common Stock (CORZ) Statistics
Core Scientific, Inc. Common Stock (CORZ) has a market cap of $4.38B and an enterprise value of $7.89B. Its share count is up 47.23% from a year earlier. Revenue grew 77.17% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 80.23% above the market cap, as debt exceeds cash.
| Market Cap | $4.38B |
|---|---|
| Enterprise Value | $7.89B |
| Latest price (Nov 17, 2026) | $13.51 |
Key Dates
The next earnings report is expected on Mar 1, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 1, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Fiscal Year End | September |
Valuation Ratios
The price to sales ratio is 10.7x.
| P/E Ratio | 37.9x |
|---|---|
| P/S Ratio | 10.7x |
| Forward P/S | 5.8x |
| P/OCF Ratio | 9.7x |
Price Statistics
The stock is down 9.51% over 52 weeks and trades 11.12% below its 50-day average.
| Beta (1Y) | 3.00 |
|---|---|
| 52-Week Change | -9.51% |
| 1-Month Change | -1.60% |
| 3-Month Change | -27.83% |
| 6-Month Change | -41.06% |
| Total Return (1Y) | -9.51% |
| Return vs SPY (1Y) | -24.00% |
| Max Drawdown (1Y) | -60.97% |
| Max Drawdown (3Y) | -64.95% |
| Sharpe Ratio (1Y) | -0.18 |
| Correlation with SPY (1Y) | 0.55 |
| 50-Day Average | $15.20 |
| 200-Day Average | $19.33 |
| 52-Week Range | $10.59 to $30.46 |
| RSI (14 Days) | 47.0 |
| Average Volume (20 Days) | 17.29M |
Financial Position
Current assets cover 0.67x current liabilities.
| Current Ratio | 0.67x |
|---|---|
| Quick Ratio | 0.67x |
| Interest Coverage | -2.31x |
Returns and Efficiency
Return on invested capital is -3.01% over the last 12 months, against a 5-year average of -65.45%.
| Return on Assets (ROA) | -1.86% |
|---|---|
| Return on Invested Capital (ROIC) | -3.01% |
| Return on Capital Employed (ROCE) | -3.90% |
| ROA (5Y Average) | -78.59% |
| ROIC (5Y Average) | -65.45% |
| Asset Turnover | 0.14x |
| Receivables Turnover | 1.78x |
Scores
CORZ has an Altman Z-Score of -0.64, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -0.64 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 4 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was $592.07M over the last 12 months.
| Revenue | $592.07M |
|---|---|
| Revenue Growth (YoY) | +77.17% |
| Gross Profit | $243.95M |
| Operating Income | -$10.51M |
| Pretax Income | -$214.12M |
| Net Income | -$110.22M |
| EBIT | -$149.47M |
| Reported EPS (TTM) | $0.36 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
| Cash and Equivalents | $803.94M |
|---|---|
| Total Debt | $4.31B |
| Net Debt | $3.51B |
| Net Debt Per Share | $7.49 |
| Working Capital | -$685.06M |
| Shareholder Equity | -$1.09B |
| Tangible Book Value | -$1.83B |
| Total Assets | $5.94B |
| Total Liabilities | $7.03B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $1.77B of capital spending, operating cash flow left -$1.32B of free cash flow.
| Operating Cash Flow | $449.31M |
|---|---|
| Capital Expenditures | $1.77B |
| Free Cash Flow | -$1.32B |
| FCF Per Share | -$4.10 |
| Depreciation and Amortization | $59.15M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -1.78%, against a 5-year average of -15.99%.
| Gross Margin | 41.20% |
|---|---|
| Operating Margin | -1.78% |
| Pretax Margin | -36.16% |
| Net Margin | -18.62% |
| EBIT Margin | -25.24% |
| FCF Margin | -223.03% |
| Gross Margin (5Y Average) | 21.07% |
| Operating Margin (5Y Average) | -15.99% |
Growth
Revenue fell 20.72% a year over 3 years.
| Revenue Growth (3Y CAGR) | -20.72% |
|---|---|
| Revenue Growth (5Y CAGR) | +39.53% |
Dividends and Yields
CORZ does not pay a dividend. Its free cash flow yield is -20.84%.
| Earnings Yield | 2.64% |
|---|---|
| FCF Yield | -20.84% |
| Shareholder Yield | 0.00% |
Peer Position
Against 7 similar companies, CORZ has the 2nd highest P/E.
P/E RatioPeer median 14.5x
P/S RatioPeer median 4.5x
ROICPeer median 6.89%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +15.95%
| P/E Ratio | 37.9x vs 14.5x median |
|---|---|
| P/S Ratio | 10.7x vs 4.5x median |
| ROIC | -3.01% vs 6.89% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +77.17% vs +15.95% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About CORZ
What is CORZ's market cap?
Core Scientific, Inc. Common Stock has a market cap of $4.38B. Its enterprise value, which adds debt and subtracts cash, is $7.89B.
What is CORZ's P/E ratio?
Core Scientific, Inc. Common Stock has a trailing P/E ratio of 37.9x.
How many shares of CORZ are outstanding?
Core Scientific, Inc. Common Stock has 469.01M shares outstanding. The count is up 47.23% from a year earlier.
Does CORZ pay a dividend?
No. Core Scientific, Inc. Common Stock does not pay a dividend.
How much debt does CORZ have?
Core Scientific, Inc. Common Stock has $4.31B of total debt and $803.94M of cash and equivalents, a net debt position of $3.51B.
CORZ pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors